KP
IBD icon

Keel Point’s Inspire Corporate Bond ETF IBD Stock Holding History

Keel Point’s Portfolio IBD Stock Details IBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$592K Buy
24,795
+898
+4% +$21.6K 0.04% 245
2025
Q4 		$578K Sell
23,897
-61
-0.3% -$1.48K 0.03% 265
2025
Q3 		$579K Buy
23,958
+1,144
+5% +$27.5K 0.04% 270
2025
Q2 		$548K Hold
22,814
– – 0.04% 274
2025
Q1 		$542K Sell
22,814
-4,123
-15% -$97.4K 0.04% 238
2024
Q4 		$631K Buy
26,937
+1,158
+4% +$27.5K 0.05% 198
2024
Q3 		$621K Buy
25,779
+8
+0% +$191 0.05% 203
2024
Q2 		$616K Sell
25,771
-53,856
-68% -$1.25M 0.06% 200
2024
Q1 		$1.87M Sell
79,627
-26,837
-25% -$631K 0.19% 85
2023
Q4 		$2.51M Buy
106,464
+505
+0.5% +$11.5K 0.3% 65
2023
Q3 		$2.4M Buy
105,959
+1,993
+2% +$45.8K 0.33% 61
2023
Q2 		$2.4M Buy
103,966
+1,388
+1% +$32.3K 0.32% 62
2023
Q1 		$2.4M Buy
102,578
+2,810
+3% +$65.3K 0.35% 59
2022
Q4 		$2.3M Buy
99,768
+24,830
+33% +$567K 0.36% 61
2022
Q3 		$1.7M Sell
74,938
-81
-0.1% -$1.9K 0.29% 64
2022
Q2 		$1.79M Buy
75,019
+9,310
+14% +$221K 0.28% 67
2022
Q1 		$1.6M Buy
65,709
+12,304
+23% +$307K 0.24% 76
2021
Q4 		$1.38M Buy
53,405
+376
+0.7% +$9.74K 0.15% 92
2021
Q3 		$1.39M Sell
53,029
-506
-0.9% -$13.3K 0.18% 92
2021
Q2 		$1.41M Sell
53,535
-3,405
-6% -$89K 0.16% 99
2021
Q1 		$1.47M Buy
56,940
+3,936
+7% +$103K 0.14% 106
2020
Q4 		$1.41M Buy
53,004
+3,245
+7% +$85.8K 0.13% 105
2020
Q3 		$1.31M Buy
49,759
+9,126
+22% +$241K 0.12% 94
2020
Q2 		$1.07M Buy
40,633
+6,068
+18% +$155K 0.11% 90
2020
Q1 		$842K Buy
34,565
+17,362
+101% +$441K 0.11% 88
2019
Q4 		$442K Hold
17,203
– – 0.05% 125
2019
Q3 		$442K Hold
17,203
– – 0.05% 125
2019
Q2 		$441K Hold
17,203
– – 0.05% 131
2019
Q1 		$432K Buy
17,203
+406
+2% +$10K 0.05% 135
2018
Q4 		$410K Hold
16,797
– – 0.06% 136
2018
Q3 		$411K Hold
16,797
– – 0.05% 120
2018
Q2 		$410K Hold
16,797
– – 0.05% 103
2018
Q1 		$411K Buy
16,797
+1,781
+12% +$44.3K 0.06% 102
2017
Q4 		$379K Buy
+15,016
New +$378K 0.05% 119

Other funds holding IBD

IA
Inspire Advisors Meridian, Idaho $1.23B AUM 18.62% 1-Year Est. Return
FA
Faithward Advisors Lancaster, Pennsylvania $701M AUM 32.17% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return
II
Inspire Investing Meridian, Idaho $1.71B AUM 31.76% 1-Year Est. Return
BFS
Bare Financial Services Gap, Pennsylvania $378M AUM 15.71% 1-Year Est. Return
OFS
OneAscent Financial Services Birmingham, Alabama $1.85B AUM 18.45% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
PFG
PAX Financial Group San Antonio, Texas $586M AUM 15.84% 1-Year Est. Return
PAW
Plan A Wealth Lincoln, Nebraska $235M AUM 22.68% 1-Year Est. Return

Keel Point's IBD Position: Q1 2026 in Review

Keel Point increased its Inspire Corporate Bond ETF (IBD) stake by 3.8% in Q1 2026, buying an estimated $21.6K and bringing the position to 24,795 shares worth $592K. The position accounts for 0.04% of the portfolio, ranked #245.

Keel Point first reported a position in IBD in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.51M in Q4 2023. 106 funds tracked by Wall St. Rank hold IBD as of Q1 2026.

  • Keel Point held 24,795 shares of Inspire Corporate Bond ETF worth $592K as of Q1 2026.
  • Keel Point bought 898 Inspire Corporate Bond ETF shares in Q1 2026, an estimated $21.6K.
  • Inspire Corporate Bond ETF made up 0.04% of Keel Point's portfolio in Q1 2026, its #245 holding.
  • Keel Point first reported a position in Inspire Corporate Bond ETF in Q4 2017 and has held it in 34 quarters since.
  • Keel Point's Inspire Corporate Bond ETF position peaked at $2.51M in Q4 2023.
  • 106 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2026.

Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.